期刊文献+

三维适形调强放疗联合DP化疗方案治疗局部晚期鼻咽癌的效果探析 被引量:3

下载PDF
导出
摘要 目的 :探讨使用三维适形调强放疗联合DP化疗方案治疗局部晚期鼻咽癌对患者肿瘤局部控制率及生活质量的影响。方法 :选取2014年2月至2015年12月期间广西壮族自治区钦州市第一人民医院收治的86例局部晚期鼻咽癌患者作为研究对象。随机将这些患者分为对照组(n=43)和观察组(n=43)。对两组患者均进行三维适形调强放疗。在此基础上,对观察组患者使用DP化疗方案进行治疗。然后观察两组患者肿瘤局部控制率及治疗前后其健康调查简表(SF-36)评分。结果 :治疗后,观察组患者肿瘤的局部控制率及SF-36评分均高于对照组患者(P<0.05)。结论 :使用三维适形调强放疗联合DP化疗方案治疗局部晚期鼻咽癌可提高患者肿瘤的局部控制率,改善其生活质量。
作者 郑宪艳
出处 《当代医药论丛》 2018年第2期59-60,共2页
  • 相关文献

参考文献4

二级参考文献42

  • 1吴金通,彭俊英,吴陈宾,丁纪涛.TPF方案诱导化疗对局部晚期鼻咽癌临床疗效的影响[J].实用癌症杂志,2014,29(2):143-145. 被引量:8
  • 2Xu J,He X,Cheng K,et al.Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma:Survival and toxicity[J] .Head.
  • 3Xu JH,Guo WJ,Bian XH,et al.A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy[J] .Cance.
  • 4Peng PJ,Ou XQ,Chen ZB,et al.Multicenter phaseⅡstudy of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-.
  • 5Peng PJ,Ou XQ,Chen ZB,et al.Multicenter phaseⅡstudy of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-.
  • 6Rodrigo JP,Coca-Pelaz A,Sudrez C. The current role of partialsurgery as a strategy for functional preservation in laryngeal carcinoma[J]. Acta Otorrinolaringol Esp, 2011, 62 (3) : 231- 238.
  • 7Vokes EE. Induction chemotherapy for head and neck cancer: recent data[J]. Oncologist, 2010,15 (Suppl 3) : 3-7.
  • 8Loo SW,Geropantas K, Roques TW. Functional organ preser- vation in locally advanced laryngeal squamous cell carcinoma., is there a role for induction chemotherapy[J]? Clin Oncol (R Coll Radiol), 2013,25 (5) : 298-307.
  • 9Lorch JH,Goloubeva O, Haddad RI, et al. Induction chemo- therapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial[J]. Lancet Oncol,2011,12(2) : 153-159.
  • 10Blanchard P, Bourhis J, Laeas t3, et al. Taxane-cisplatin- fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group[J]. J Clin Oncol, 2013,31(23) : 2854-2860.

共引文献23

同被引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部